MedTrace Logo

Implementation of Pharmacogenetic Testing in Hospital Wards

NCT04573491 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2023-03-09

No results posted yet for this study

Summary

The purpose of this study is to investigate whether it is feasible to implement pharmacogenetic testing as part of medication review while the patient is admitted to hospital.

Conditions

  • Admitted Multimorbid Patients

Interventions

GENETIC

Pharmacogenetic test

genotyping for genes that affect drug metabolism

OTHER

Medication review

systematic and interdisciplinary method aiming to increase quality of medication treatment

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Diakonhjemmet Hospital

    collaborator OTHER

  • University of Oslo School of Pharmacy

    collaborator OTHER

  • Hospital Pharmacy Enterprise, South Eastern Norway

    lead OTHER

Principal Investigators

  • Kathrin Bjerknes, Ph.D · Hospital Pharmacy Enterprise, South Eastern Norway

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-05
Primary Completion
2021-11-01
Completion
2021-11-01

Countries

  • Norway

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04573491 on ClinicalTrials.gov